Israel - hebraisk - Ministry of Health

manon pharm ltd. - buclizine hydrochloride; codeine phosphate; paracetamol - טבליה - paracetamol 500 mg; codeine phosphate 8 mg; buclizine hydrochloride 6.25 mg - buclizine, combinations - buclizine, combinations - treatment of migraine attacks, including accompanying symptoms: headache, nausea and vomiting.

Israel - hebraisk - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

Israel - hebraisk - Ministry of Health

teva israel ltd - entecavir as monohydrate - טבליות מצופות פילם - entecavir as monohydrate 0.5 mg - entecavir

Israel - hebraisk - Ministry of Health

teva israel ltd - entecavir as monohydrate - טבליות מצופות פילם - entecavir as monohydrate 1 mg - entecavir

Israel - hebraisk - Ministry of Health

teva israel ltd - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 5 mg - terazosin

Israel - hebraisk - Ministry of Health

teva israel ltd - naproxen sodium - טבליה - naproxen sodium 275 mg - naproxen

Israel - hebraisk - Ministry of Health

sanofi israel ltd - eliglustat - קפסולה קשיחה - eliglustat 84.4 mg - eliglustat

Israel - hebraisk - Ministry of Health

tzamal bio-pharma ltd - doxylamine succinate; pyridoxine (vit b6) hydrochloride - טבליות עם שחרור נרחב - doxylamine succinate 20 mg; pyridoxine (vit b6) hydrochloride 20 mg - doxylamine

Israel - hebraisk - Ministry of Health

teva israel ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - hebraisk - Ministry of Health

teva israel ltd - benzocaine; bismuth oxychloride; menthol; thymol biiodide; zinc oxide - משחה - zinc oxide 10 %w/w; benzocaine 4 %w/w; menthol 0.25 %w/w; bismuth oxychloride 8 %w/w; thymol biiodide 2 %w/w - bismuth preparations, combinations - bismuth preparations, combinations - symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.